ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Calculating The Intrinsic Value Of ResMed Inc. (NYSE:RMD) [Yahoo! Finance]
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Sleep Apnea Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts [Yahoo! Finance]
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.